|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项
9 A3 b0 w7 z* H) b* W! b01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.
4 p/ I) b4 N4 w8 v02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor.
1 |1 R+ B# t1 D+ F5 N! u$ t% L03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.0 q& Y0 {% P& {0 w$ ~
04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.3 G! _& E% o. K6 A/ v
05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.* B/ \2 H9 D2 X/ \, o, }
06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.
$ `0 E* A' V3 }0 M' j# m07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.
/ e Q- x5 |' D, g: `& T1 i# y% f08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.# y: o! `* l" b
09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.2 f4 G1 |" A' t# ^
10.Interpretable machine learning for prostate biopsy: Cohort study.
. f% y Q% S2 v11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.6 O! N" N( S, c9 [: B. S2 l4 r
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.
$ m+ T4 ^$ ~( Y5 A5 E6 M13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).5 b" r: [" y3 j, O5 r9 c0 f2 |
14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03)./ ]8 d% Y4 m. s* F4 u0 R+ l
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.- r, j/ u* L: m: B+ t! \
16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
) \$ O9 O l: Z' O1 A. C17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.
5 z: a' v8 y) M5 ^% I& y; F18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.9 ?# O9 b1 N$ a: s. {8 M1 Y
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.
9 a$ x1 d2 x1 X, ~$ J2 C; R6 K7 M( R; b20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.2 s, F* U- @4 `$ O- T
21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.% `" n7 F2 z1 L; G( T9 {
22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.( p K5 H' X' V X# G P
23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario., j8 Z* N4 L5 |( c8 _# m7 J7 i
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.8 D' Y& `. A) v2 c5 ^ {0 c1 x
25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.! H. M/ W) q1 w$ W8 U1 H
|
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
